These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 15991152)

  • 41. [The role of infection in the development of immune inflammation and pathogenesis of atherosclerosis].
    Nagornev VA; Mal'tseva SV
    Arkh Patol; 2000; 62(6):55-9. PubMed ID: 11198124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Atherosclerosis--a chronic infectious disease caused by Chlamydia pneumoniae].
    Stille W; Stephen C
    Versicherungsmedizin; 1999 Mar; 51(1):12-7. PubMed ID: 10200611
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The pathology of Chlamydia pneumoniae lesions in humans and animal models.
    Shor A
    Trends Microbiol; 2000 Dec; 8(12):541-2. PubMed ID: 11201259
    [No Abstract]   [Full Text] [Related]  

  • 44. [Chlamydia pneumoniae--chronic infection and atherosclerosis].
    Tiran B
    Wien Med Wochenschr; 2001; 151(24):590-3. PubMed ID: 11820175
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies.
    Boman J; Hammerschlag MR
    Clin Microbiol Rev; 2002 Jan; 15(1):1-20. PubMed ID: 11781264
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chlamydia pneumoniae in atherosclerosis.
    Saikku P
    J Intern Med; 2000 Mar; 247(3):391-6. PubMed ID: 10762457
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enigmatic relationship between Chlamydia pneumoniae and atherosclerosis.
    Zhang L; Ishikawa Y; Akasaka Y; Ito K; Ishii T
    Pathol Int; 2003 Oct; 53(10):733-4; author reply 734. PubMed ID: 14516327
    [No Abstract]   [Full Text] [Related]  

  • 48. Inflammation, infection and antimicrobial therapy in coronary heart disease--where do we currently stand?
    Ngeh J; Gupta S
    Fundam Clin Pharmacol; 2001 Apr; 15(2):85-93. PubMed ID: 11468018
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chlamydia pneumoniae-induced atherosclerosis in a rabbit model.
    Muhlestein JB
    J Infect Dis; 2000 Jun; 181 Suppl 3():S505-7. PubMed ID: 10839748
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease.
    Kalayoglu MV; Libby P; Byrne GI
    JAMA; 2002 Dec; 288(21):2724-31. PubMed ID: 12460096
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Infection with Chlamydia pneumoniae as a cause of coronary heart disease: the hypothesis is still untested.
    Grayston JT; Belland RJ; Byrne GI; Kuo CC; Schachter J; Stamm WE; Zhong G
    Pathog Dis; 2015 Feb; 73(1):1-9. PubMed ID: 25854002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chlamydia pneumoniae and atherosclerosis.
    Belland RJ; Ouellette SP; Gieffers J; Byrne GI
    Cell Microbiol; 2004 Feb; 6(2):117-27. PubMed ID: 14706098
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of infection in atherosclerosis and coronary artery disease: a new therapeutic target?
    Frishman WH; Ismail AA
    Cardiol Rev; 2002; 10(4):199-210. PubMed ID: 12144730
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for infectious agents in cardiovascular disease and atherosclerosis.
    Leinonen M; Saikku P
    Lancet Infect Dis; 2002 Jan; 2(1):11-7. PubMed ID: 11892489
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Chlamydia pneumoniae - causal pathogen or fortuitous witness of atherosclerosis progression?].
    Tracz W
    Kardiol Pol; 2009 Sep; 67(9):987-8. PubMed ID: 19938364
    [No Abstract]   [Full Text] [Related]  

  • 56. [Chlamydia pneumoniae and atherosclerosis].
    Fortini A; Corti G; Cappelletti C
    Ann Ital Med Int; 1999; 14(4):253-63. PubMed ID: 10638018
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Chlamydia pneumoniae and its relation with human atherosclerosis].
    Gutiérrez J; Linares-Palomino J; Rodríguez M; Maroto MC
    Rev Invest Clin; 2000; 52(5):482-6. PubMed ID: 11195174
    [No Abstract]   [Full Text] [Related]  

  • 58. Chlamydia pneumoniae, antibiotic treatment, and early atherosclerosis.
    Liuba P; Pesonen E; Paakkari I
    Circulation; 2003 Jun; 107(22):e205; author reply e205. PubMed ID: 12796417
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae.
    Rothstein NM; Quinn TC; Madico G; Gaydos CA; Lowenstein CJ
    J Infect Dis; 2001 Jan; 183(2):232-238. PubMed ID: 11120929
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical manifestations of atherosclerosis in an elderly population are related to plasma neopterin, NGAL and endothelin-1, but not to Chlamydia pneumoniae serology.
    Forsblad J; Gottsäter A; Persson K; Jacobsson L; Lindgärde F
    Int Angiol; 2002 Jun; 21(2):173-9. PubMed ID: 12110780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.